Exisulind in combination with celecoxib modulates epidermal growth factor receptor, cyclooxygenase-2, and cyclin D1 against prostate carcinogenesis: in vivo evidence.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples